デフォルト表紙
市場調査レポート
商品コード
1705438

マルチオミクスの世界市場レポート 2025

Multiomics Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
マルチオミクスの世界市場レポート 2025
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マルチオミクス市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率(CAGR)17.6%で73億8,000万米ドルに成長します。予測期間の成長は、人工知能や機械学習の進歩、臨床アプリケーションの拡大、バイオ医薬品産業の成長、統合型マルチオミクスプラットフォームの出現、農業や環境調査での利用の増加などに起因すると考えられます。予測期間における主な動向としては、技術的進歩、新しい商用マルチオミクスプラットフォームの立ち上げ、空間分解マルチオミクス分析の採用、バイオ医薬研究開発への採用、臨床診断への拡大などが挙げられます。

個別化医療に対する需要の高まりが、マルチオミクス市場の成長を促進する見通しです。個別化医療は、遺伝的、環境的、ライフスタイル的要因に基づいて、個々の患者に合わせてヘルスケアの決定や治療を行うもので、テクノロジーの進歩、標的治療へのニーズの高まり、世界ヘルスケアの改善により、支持を集めています。マルチオミクスは、個人の遺伝的、分子的、代謝的プロファイルを包括的に理解することで、医療提供者が各患者の特性に合わせて治療をカスタマイズできるようにし、個別化医療において重要な役割を果たしています。例えば、米国を拠点とする非営利団体である個別化医療連合(Personalized Medicine Coalition)の報告によると、2024年2月、FDAは希少疾患患者を対象に、2022年の6件に対し、2023年には16件の新規個別化治療を承認しました。このように、個別化医療に対する需要の高まりが、マルチオミクス市場の拡大に拍車をかけています。

マルチオミクス市場の主要企業は、サンプルの完全性を損なうことなく大規模研究を促進するために、先進的なシングルセルマルチオミクスプラットフォームの開発に注力しています。シングルセルマルチオミクスプラットフォームは、様々なオミックスと人工知能機能を統合し、高度なアルゴリズムと機械学習技術によって複雑な生物学的データの解析と解釈を可能にします。例えば、2023年2月、米国の医療機器会社であるBecton, Dickinson, and Company社は、高スループットのシングルセルマルチオミクスプラットフォームであるBD Rhapsody HT Xpressを発表しました。この最先端のシステムは、科学者が高いサンプルスループットで単一細胞を分離、バーコード化、分析することを可能にし、従来のBD単一細胞分析装置の最大8倍の細胞数に対応します。BD Rhapsody HT Xpressシステムは、サンプルのロスを最小限に抑え、幹細胞やがん細胞など、複数のサンプルや異なるサイズ・種類の細胞を同時に分析する柔軟性を提供し、研究者の知見を効率的に得る能力を高めます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界マルチオミクス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のマルチオミクス市場:成長率分析
  • 世界のマルチオミクス市場の実績:規模と成長, 2019-2024
  • 世界のマルチオミクス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界マルチオミクス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のマルチオミクス市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単一細胞マルチオミクス
  • 一括マルチオミクス
  • 世界のマルチオミクス市場:プラットフォーム別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ゲノミクス
  • トランスクリプトミクス
  • プロテオミクス
  • メタボロミクス
  • 統合オミクスプラットフォーム
  • 世界のマルチオミクス市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断
  • 医薬品の発見と開発
  • パーソナライズ医療
  • アグリゲノミクス
  • その他の用途
  • 世界のマルチオミクス市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 学術調査機関
  • 製薬およびバイオテクノロジー企業
  • 臨床調査組織
  • その他のエンドユーザー
  • 世界のマルチオミクス市場、単一細胞マルチオミクスのサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • シングルセルゲノミクス
  • シングルセルトランスクリプトミクス
  • 単一細胞エピゲノミクス
  • シングルセルプロテオミクス
  • 単一細胞メタボロミクス
  • 世界のマルチオミクス市場バルクマルチオミクスのサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ゲノミクス
  • トランスクリプトミクス
  • エピゲノミクス
  • プロテオミクス
  • メタボロミクス

第7章 地域別・国別分析

  • 世界のマルチオミクス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のマルチオミクス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • マルチオミクス市場:競合情勢
  • マルチオミクス市場:企業プロファイル
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Agilent Technologies Inc.
  • Illumina Inc.
  • Shimadzu Corporation
  • Bruker Corporation
  • Bio-Techne
  • Azenta Life Sciences
  • 10x Genomics
  • Ginkgo Bioworks
  • Abcam limited
  • BioLegend
  • Oxford Nanopore Technologies Plc
  • Adaptive Biotechnologies
  • Pacific Biosciences
  • Standard BioTools
  • Parse Biosciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • マルチオミクス市場2029:新たな機会を提供する国
  • マルチオミクス市場2029:新たな機会を提供するセグメント
  • マルチオミクス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30748

Multiomics refers to the integration and analysis of multiple omics data types, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, to gain a more comprehensive understanding of biological systems. This approach enhances comprehension of complex diseases, facilitates biomarker identification, and contributes to precision medicine initiatives.

The primary categories of multiomics are single-cell multiomics and bulk multiomics. Single-cell multiomics entails analyzing various biological molecules, such as DNA, RNA, proteins, and metabolites, within individual cells. It offers diverse platforms, such as genomics, transcriptomics, proteomics, metabolomics, and integrated omics platforms, for applications such as diagnostics, drug discovery and development, personalized medicine, agrigenomics, and others. These techniques are utilized by various end users, including academic and research institutions, pharmaceutical and biotechnology firms, clinical research organizations, and others.

The multiomics market research report is one of a series of new reports from The Business Research Company that provides multiomics market statistics, including the multiomics industry global market size, regional shares, competitors with multiomics market share, detailed multiomics market segments, market trends, and opportunities, and any further data you may need to thrive in the multiomics industry. These multiomics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The multiomics market size has grown rapidly in recent years. It will grow from $3.27 billion in 2024 to $3.85 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to Increased biomedical research, increased government and private funding, a rise in the prevalence of chronic diseases, technological advancements, and enhanced computational tools and software for data analysis.

The multiomics market size is expected to see rapid growth in the next few years. It will grow to $7.38 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to advances in artificial intelligence and machine learning, expansion of clinical applications, growing biopharmaceutical industry, emergence of integrated multiomics platforms, and increasing use in agricultural and environmental research. Major trends in the forecast period include technological advancements, the launch of new commercial multiomics platforms, the adoption of spatially resolved multiomics analysis, adoption in biopharmaceutical research and development, and expansion into clinical diagnostics.

The increasing demand for personalized medicine is poised to propel the growth of the multiomics market. Personalized medicine, which tailors healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors, is gaining traction due to advancements in technology, a growing need for targeted therapies, and improvements in global healthcare. Multiomics plays a crucial role in personalized medicine by offering a comprehensive understanding of an individual's genetic, molecular, and metabolic profile, empowering healthcare providers to customize treatments according to each patient's unique characteristics. For instance, in February 2024, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022, as reported by the Personalized Medicine Coalition, a US-based non-profit organization. Thus, the increasing demand for personalized medicine is fueling the expansion of the multiomics market.

Leading companies in the multiomics market are focusing on developing advanced single-cell multiomics platforms to facilitate large-scale studies without compromising sample integrity. Single-cell multiomics platforms integrate various omics with artificial intelligence capabilities, enabling users to analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For example, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, introduced the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This cutting-edge system allows scientists to isolate, barcode, and analyze single cells with high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures minimal sample loss and offers flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, thereby enhancing researchers' ability to gain insights efficiently.

In October 2022, Clinical Microbiomics, a Denmark-based biotechnology company, acquired MS-Omics for an undisclosed amount. This strategic acquisition bolsters Clinical Microbiomics' leadership in the microbiome field and significantly enhances its capabilities in analyzing and understanding the intricate interactions within the microbiome. The acquisition enables Clinical Microbiomics to provide a comprehensive suite of multi-omics solutions tailored to the microbiome, offering valuable insights into its role in human health and disease. MS-Omics, based in Denmark, specializes in multiomics, including metabolomics.

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

North America was the largest region in the multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the multiomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The multiomics market consists of revenues earned by entities by providing services such as experimental design, sample preparation, data analysis, and data generation. The market value includes the value of related goods sold by the service provider or included within the service offering. The multiomics market also includes sales of instruments, consumables and reagents, microarrays, bioinformatics workstations and servers, and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Single-Cell Multiomics; Bulk Multiomics
  • 2) By Platform: Genomics; Transcriptomics; Proteomics; Metabolomics; Integrated Omics Platforms
  • 3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; AgriGenomics; Other Applications
  • 4) By End User: Academics And Research Organization; Pharmaceutical And Biotechnology Companies; Clinical research Organization; Other End-Users
  • Subsegments:
  • 1) By Single-Cell Multiomics: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Epigenomics; Single-Cell Proteomics; Single-Cell Metabolomics
  • 2) By Bulk Multiomics: Genomics; Transcriptomics; Epigenomics; Proteomics; Metabolomics
  • Companies Mentioned: Bayer AG; Thermo Fisher Scientific Inc.; Novartis AG; Becton Dickinson and Company; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiomics Market Characteristics

3. Multiomics Market Trends And Strategies

4. Multiomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Multiomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Multiomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Multiomics Market Growth Rate Analysis
  • 5.4. Global Multiomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Multiomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Multiomics Total Addressable Market (TAM)

6. Multiomics Market Segmentation

  • 6.1. Global Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell Multiomics
  • Bulk Multiomics
  • 6.2. Global Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms
  • 6.3. Global Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Discovery And Development
  • Personalized Medicine
  • AgriGenomics
  • Other Applications
  • 6.4. Global Multiomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academics And Research Organization
  • Pharmaceutical And Biotechnology Companies
  • Clinical research Organization
  • Other End-Users
  • 6.5. Global Multiomics Market, Sub-Segmentation Of Single-Cell Multiomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell Genomics
  • Single-Cell Transcriptomics
  • Single-Cell Epigenomics
  • Single-Cell Proteomics
  • Single-Cell Metabolomics
  • 6.6. Global Multiomics Market, Sub-Segmentation Of Bulk Multiomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomics
  • Transcriptomics
  • Epigenomics
  • Proteomics
  • Metabolomics

7. Multiomics Market Regional And Country Analysis

  • 7.1. Global Multiomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Multiomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiomics Market

  • 8.1. Asia-Pacific Multiomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiomics Market

  • 9.1. China Multiomics Market Overview
  • 9.2. China Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiomics Market

  • 10.1. India Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiomics Market

  • 11.1. Japan Multiomics Market Overview
  • 11.2. Japan Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiomics Market

  • 12.1. Australia Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiomics Market

  • 13.1. Indonesia Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiomics Market

  • 14.1. South Korea Multiomics Market Overview
  • 14.2. South Korea Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiomics Market

  • 15.1. Western Europe Multiomics Market Overview
  • 15.2. Western Europe Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiomics Market

  • 16.1. UK Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiomics Market

  • 17.1. Germany Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiomics Market

  • 18.1. France Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiomics Market

  • 19.1. Italy Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiomics Market

  • 20.1. Spain Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiomics Market

  • 21.1. Eastern Europe Multiomics Market Overview
  • 21.2. Eastern Europe Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiomics Market

  • 22.1. Russia Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiomics Market

  • 23.1. North America Multiomics Market Overview
  • 23.2. North America Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiomics Market

  • 24.1. USA Multiomics Market Overview
  • 24.2. USA Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiomics Market

  • 25.1. Canada Multiomics Market Overview
  • 25.2. Canada Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiomics Market

  • 26.1. South America Multiomics Market Overview
  • 26.2. South America Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiomics Market

  • 27.1. Brazil Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiomics Market

  • 28.1. Middle East Multiomics Market Overview
  • 28.2. Middle East Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiomics Market

  • 29.1. Africa Multiomics Market Overview
  • 29.2. Africa Multiomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Multiomics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Multiomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiomics Market Competitive Landscape And Company Profiles

  • 30.1. Multiomics Market Competitive Landscape
  • 30.2. Multiomics Market Company Profiles
    • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Multiomics Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. Shimadzu Corporation
  • 31.4. Bruker Corporation
  • 31.5. Bio-Techne
  • 31.6. Azenta Life Sciences
  • 31.7. 10x Genomics
  • 31.8. Ginkgo Bioworks
  • 31.9. Abcam limited
  • 31.10. BioLegend
  • 31.11. Oxford Nanopore Technologies Plc
  • 31.12. Adaptive Biotechnologies
  • 31.13. Pacific Biosciences
  • 31.14. Standard BioTools
  • 31.15. Parse Biosciences

32. Global Multiomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiomics Market

34. Recent Developments In The Multiomics Market

35. Multiomics Market High Potential Countries, Segments and Strategies

  • 35.1 Multiomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Multiomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Multiomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer